| Date Filed | Type | Description |
| 08/07/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 117,272 shares
@ $2.539, valued at
$297.8k
Sold 150,000 shares
@ $2.4992, valued at
$374.9k
Sold 8,616 shares
@ $2.4679, valued at
$21.3k
|
|
| 08/03/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 105,944 shares
@ $2.679, valued at
$283.8k
Sold 73,704 shares
@ $2.593, valued at
$191.1k
|
|
| 05/03/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 455,528 shares
@ $2.5759, valued at
$1.2M
|
|
| 02/03/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 413,168 shares
@ $2.5572, valued at
$1.1M
|
|
| 12/21/2022 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 600,000 shares
@ $2.1151, valued at
$1.3M
|
|
| 11/03/2022 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Paid exercise price by delivering 454,856 shares
@ $1.6, valued at
$727.8k
Sold 13,160 shares
@ $1.6726, valued at
$22k
|
|
| 09/28/2022 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 3,600,000 shares
@ $0 |
|
| 08/11/2022 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 600,000 shares
@ $1.75, valued at
$1.1M
|
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 12,512 shares
@ $0.4956, valued at
$6.2k
|
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 133,776 shares
@ $0.7475, valued at
$100k
Paid exercise price by delivering 288,320 shares
@ $0.7762, valued at
$223.8k
Sold 10,416 shares
@ $0.7562, valued at
$7.9k
|
|
| 11/18/2021 |
3
| Hahn Mark W (Director) has filed a Form 3 on ALSP Orchid Acquisition Corp I |
| 11/03/2021 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Paid exercise price by delivering 454,848 shares
@ $0.64, valued at
$291.1k
Sold 10,416 shares
@ $0.6453, valued at
$6.7k
|
|
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,545 shares
@ $14.17, valued at
$21.9k
|
|
| 01/08/2019 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Granted 8,844 shares
@ $0
Granted 250,000 options to buy
@ $8.82, valued at
$2.2M
|
|
| 12/21/2018 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Bought 2,500 shares
@ $6.28, valued at
$15.7k
|
|
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2018 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Dova Pharmaceuticals, Inc.|
Txns:
| Granted 175,000 options to buy
@ $31.86, valued at
$5.6M
|
|
| 02/01/2018 |
3
| Hahn Mark W (CFO) has filed a Form 3 on Dova Pharmaceuticals, Inc. |
| 02/27/2017 |
4
| Hahn Mark W (EVP and CFO) has filed a Form 4 on CEMPRA, INC. |
| 01/05/2017 |
4
| Hahn Mark W (EVP and CFO) has filed a Form 4 on CEMPRA, INC. |
| 01/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/02/2015 |
4
| Hahn Mark W (EVP and CFO) has filed a Form 4 on CEMPRA, INC.|
Txns:
| Granted 46,363 options to buy
@ $23.51, valued at
$1.1M
|
|
| 01/10/2014 |
4
| Hahn Mark W (EVP and CFO) has filed a Form 4 on CEMPRA, INC.|
Txns:
| Granted 15,000 options to buy
@ $13.1, valued at
$196.5k
Granted 45,000 options to buy
@ $13.1, valued at
$589.5k
|
|
| 01/22/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2012 |
4
| Hahn Mark W (EVP and CFO) has filed a Form 4 on CEMPRA, INC. |
|